Image de couverture de livre

Discovery of a Highly Promising Disulfide Derivative Scaffold as Inhibitor of SARS‐CoV‐2 Main Protease

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yin‐Sui Xu, Yang Xiang, Le Zhai, Cheng Chen, Xiao‐Rong Wu, Wei‐Ya Chen, Lu Liu, Mu‐Han Zhao, Xiao‐Long Liu, Ke‐Wu Yang
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Chemistry & Biodiversity
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Computational Discovery of Natural Dual Inhibitors Targeting SARS‐CoV‐2 Main and Papain‐Like Proteases
par: Imane Yamari, et autres
Publié: (2025)

Discovery of Fluorescent Naturally‐Occurring Inhibitor of SARS‐CoV‐2 Main Protease by AIE Fluorescent Probe
par: Hao Lin, et autres
Publié: (2024)

Investigating the Inhibition of Diindolylmethane Derivatives on SARS‐CoV‐2 Main Protease
par: Wenjin Li, et autres
Publié: (2024)

Sequential Optimization Approach Toward an Azapeptide‐Based SARS‐CoV‐2 Main Protease Inhibitor
par: Rabea Voget, et autres
Publié: (2025)

Application of Angelica archangelica Phytomaterials as Inhibitors of SARS‐CoV‐2 Main Protease Receptor
par: Ruchi Kumari, et autres
Publié: (2025)

DFT Investigations and Molecular Docking as Potent Inhibitors of SARS‐CoV‐2 Main Protease of Novel Pyrimidine Dione Derivatives
par: Wesam S. Shehab, et autres
Publié: (2025)

Multistaged In Silico Discovery of the Best SARS-CoV-2 Main Protease Inhibitors amongst 3009 Clinical and FDA-Approved Compounds
par: Ibrahim H. Eissa, et autres
Publié: (2024)

Computational Discovery of MERS ‐ CoV Main Protease Inhibitors Through Screening and Molecular Dynamics Simulations
par: Shahidul M. Islam, et autres
Publié: (2026)

Systematic Reevaluation of Repurposed Drugs Against the Main Protease of SARS‐CoV‐2 via Combined Experiments
par: Jiankai Ye, et autres
Publié: (2025)

Amphibian‐Derived Peptides as Natural Inhibitors of SARS‐CoV‐2 Main Protease (M pro ): A Combined In Vitro and In Silico Approach
par: Roque Spinelli, et autres
Publié: (2025)

Exploring the Efficacy of Noncovalent SARS‐CoV‐2 Main Protease Inhibitors: A Computational Simulation Analysis Study
par: Fei Xiong, et autres
Publié: (2024)

Front Cover: Copper(II) Inhibition of the SARS‐CoV‐2 Main Protease
par: Roberto A. Garza‐López, et autres
Publié: (2025)

Protein‐Templated Ugi Reactions versus In‐Situ Ligation Screening: Two Roads to the Identification of SARS‐CoV‐2 Main Protease Inhibitors
par: Rebekka Wamser, et autres
Publié: (2024)

Dissecting the Molecular Mechanism Concerning Conformational Changes of SARS‐CoV‐2 Main Protease Mediated by Binding of Natural Phytochemicals via Molecular Dynamics Simulations
par: Chaoyue Jia, et autres
Publié: (2025)

Pomotrelvir and Nirmatrelvir Binding and Reactivity with SARS‐CoV‐2 Main Protease: Implications for Resistance Mechanisms from Computations
par: Johanna Schillings, et autres
Publié: (2024)

SARS‐CoV‐2 Main Protease Activates ERK1/2 Signaling to Facilitate MEG2–STAT3‐Mediated Suppression of ACE2
par: Uyen Nguyen Phuong Le, et autres
Publié: (2026)

Nucleoside‐Based Drug Target with General Antimicrobial Screening and Specific Computational Studies against SARS‐CoV‐2 Main Protease
par: Sarkar M. A. Kawsar, et autres
Publié: (2024)

Novel Cephalosporins Against the Main Protease of SARS CoV (M pro O, M pro WT ): Molecular Docking and DFT Study
par: Adeel Mubarik, et autres
Publié: (2024)

Computationally Efficient Network Models Successfully Predict Allosteric Sites of SARS ‐ CoV ‐2 Main Protease and Reveal Its Dynamic Allostery
par: Merve Yuce, et autres
Publié: (2026)

Tricarbonyl Rhenium‐Based PROTACs Degrade the SARS‐CoV‐2 Mpro Protease
par: Liuruiqi Luo, et autres
Publié: (2025)

Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti‐SARS‐CoV‐2 Activity
par: Christian Gege, et autres
Publié: (2024)

Marine-Derived Peptides from as Potential SARS-CoV-2 Mpro Inhibitors: An Approach.
par: Cañedo-Figueroa, David Mauricio, et autres
Publié: (2025)

Exploring the Therapeutic Potential of Algerian Propolis: GC/MS Profiling, Protective Inclusion Complex, and In Silico Evaluation Against SARS‐CoV‐2 Main Proteases
par: Zahra Toutou, et autres
Publié: (2024)

Main Protease From SARS‐CoV‐2 Dysregulates Glucose Handling in the C2C12 Cell Line In Vitro: A Mechanistic Study
par: Praise Tatenda Nhau, et autres
Publié: (2026)

Discovery of Potent Quinazolinone Inhibitors Against SARS‐CoV‐2 Mpro via an Integrated Computational Strategy
par: Renato Araújo da Costa, et autres
Publié: (2026)

QSAR‐Based Machine Learning Reveals a Repurposed Dual‐Function G4 Ligand against Ensitrelvir‐Resistant SARS‐CoV‐2 Main Protease
par: Napat Prompat, et autres
Publié: (2025)

Inhibition Potential of Quercetin Similar Compounds to SARS‐CoV‐2 Main Protease by High‐Throughput Virtual Screening, Molecular Simulations, ADMET Analysis, and DFT Studies
par: Kalpana Gyawali, et autres
Publié: (2025)

Discovery of a Novel Public Antibody Lineage Correlated With Inactivated SARS‐CoV‐2 Vaccine and the Resultant Neutralization Activity
par: Jing Wang, et autres
Publié: (2024)

Synthesis and Evaluation of Thiosemicarbazone Inhibitors for SARS‐CoV‐2 Mpro by Spectroscopy and Microscale Thermophoresis
par: Leyao Chen, et autres
Publié: (2025)

Proteomics and Phosphoproteomics Characteristics of the Rhesus Macaque Lung Infected With Original SARS‐CoV‐2, Delta, and Omicron Variants
par: XiaoYue Tang, et autres
Publié: (2025)

Albendazole Suppresses SARS‐CoV‐2 Replication by Enhancing HERC5‐Mediated ISGylation of Nucleocapsid Protein
par: Yezi Wu, et autres
Publié: (2025)

Miniaturized Modular Click Chemistry‐enabled Rapid Discovery of Unique SARS‐CoV‐2 Mpro Inhibitors With Robust Potency and Drug‐like Profile
par: Mianling Yang, et autres
Publié: (2024)

Integrative Multi‐Omics Analysis Reveals Age‐Associated Molecular Mechanisms in SARS‐CoV‐2 Infection
par: Xiaoyue Tang, et autres
Publié: (2025)

In Silico and In Vitro Screening of Some Pregnane Glycosides Isolated from Certain Caralluma Species as SARS‐COV‐2 Main Protease Inhibitors
par: Essam Abdel‐Sattar, et autres
Publié: (2024)

A Versatile DNAzyme‐Amplified Protease‐Sensing Platform for Accurate Diagnosis of SARS‐CoV‐2 and Reliable Classification of Colorectal Cancer
par: Benrui Weng, et autres
Publié: (2025)

Molecular Docking, Dynamics Simulations, ADMET, and DFT Calculations: Combined In Silico Approach to Screen Natural Inhibitors of 3CL and PL Proteases of SARS-CoV-2
par: Sugumar Mohanasundaram, et autres
Publié: (2024)

Optimum timing of lung resection surgery following SARS‐CoV‐2 infection for non‐small cell lung cancer
par: Yanbo Yang, et autres
Publié: (2024)

Clinical Features of Central Nervous System Complications Caused by the SARS‐CoV‐2 Omicron Variant
par: Tingting Li, et autres
Publié: (2025)

Seroprevalence of SARS‐CoV‐2 Antibody Before and After Both Vaccination and Natural Infection in China
par: Yang Guang, et autres
Publié: (2025)

Fluorescence Resonance Energy Transfer Assay at the Crossroad: Urgent Reexamination of Assay Design for Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors
par: Jiankai Ye, et autres
Publié: (2026)